Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025International Journal of Biology and Life SciencesOpen Access

Research Progress on the Mechanism Exploration and Clinical Application of Traditional Chinese Medicine in Treating Non-Small Cell Lung Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

KYKai Yang

Discussion

Loading...

Member takes

Overview

Review highlights the efficacy of traditional chinese medicine in treating non-small cell lung cancer, suggesting new combined therapies.

Key Points

  • Traditional chinese medicine significantly enhances the efficacy and reduces toxicity of treatments for non-small cell lung cancer, improving quality of life.
  • Active ingredients of traditional chinese medicine can block tumor cell cycles and induce apoptosis, potentially overcoming drug resistance in patients.
  • Combining traditional chinese medicine with standard therapies like chemotherapy and radiotherapy reduces side effects, enhancing overall treatment effectiveness.
  • Numerous recent clinical studies demonstrate the multi-target benefits of traditional chinese medicine in the treatment of non-small cell lung cancer.

Cite This Study

Kai Yang (2025) studied this question.

synapsesocial.com/papers/68bb3ef72b87ece8dc95797ehttps://doi.org/10.54097/v2y85068
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Application and Pathway Regulation of Traditional Chinese Medicine in Lung Cancer Treatment: An Exploratory Review2024
  2. 2Traditional Chinese Medicine for lung cancer: Mechanisms, clinical evidence, and future perspectives2026 · 1 citations
  3. 3Traditional Chinese medicine combined with chemotherapy in the treatment of advanced non-small cell lung cancer: Key drug screening and mechanism analysis2024
  4. 4Research Progress of Traditional Chinese Medicine in Immune Function of Lung Cancer Patients2024
  5. 5Clinical efficacy of comprehensive traditional Chinese medicine in adjuvant therapy for stage Ib-IIIa resected non-small cell lung cancer: a multi-center, randomized, double-blind, placebo-controlled trial2026